North America Urology Devices Market Size, Share, and Growth Forecast 2026 - 2033

The North America urology devices market is expected to be valued at US$15.2 billion in 2026 and is projected to reach US$23.5 billion, expanding at a CAGR of 6.4% between 2026 and 2033.

The market is primarily driven by the rising prevalence of urological disorders, including kidney stone disease, benign prostatic hyperplasia (BPH), urinary incontinence, prostate cancer, and other urinary tract conditions, increasing the demand for advanced diagnostic and therapeutic devices across hospitals, ambulatory surgical centers (ASCs), and specialty urology clinics. The growing aging population in North America is further contributing to market expansion, as age-associated urological conditions become increasingly prevalent.

In addition, technological advancements in minimally invasive procedures, endoscopy, laser and lithotripsy systems, urodynamic technologies, and robotic-assisted interventions are improving treatment precision, reducing recovery times, and supporting the adoption of advanced urology devices. Growing preference for outpatient procedures, rising healthcare expenditure, investments in healthcare infrastructure, and favorable reimbursement frameworks are further strengthening market growth.

Moreover, increasing awareness of early diagnosis and the continued development of high-definition endoscopic systems, flexible urology devices, imaging-guided interventions, and advanced catheter technologies are expected to create additional opportunities in the North American urology devices market through 2033.

Drivers - Rising Prevalence of Urological Disorders Driving Demand for Advanced Urology Devices

The increasing prevalence of urological disorders, including kidney stone disease, benign prostatic hyperplasia (BPH), urinary incontinence, bladder cancer, prostate cancer, urinary tract infections, and other urinary conditions, is a major factor supporting the growth of the North America urology devices market.

The rising incidence of these conditions is closely associated with the aging population, increasing obesity and diabetes rates, sedentary lifestyles, and changing dietary patterns, which collectively increase the need for diagnostic and therapeutic urological procedures. Hospitals, ambulatory surgical centers, and specialty urology clinics are experiencing growing procedure volumes for cystoscopy, ureteroscopy, laser lithotripsy, prostate procedures, and urodynamic testing, thereby increasing demand for advanced urology devices.

Furthermore, greater awareness of early diagnosis, improved access to specialized healthcare services, rising healthcare expenditure, and continued investments in healthcare infrastructure are enabling more patients to receive timely urological treatment. Government initiatives supporting disease screening and investments in advanced medical technologies are also encouraging procedural growth, while the increasing preference for minimally invasive interventions continues to strengthen demand for innovative urology devices across the U.S. and Canada.

Continuous Advancements in Minimally Invasive and Robotic-Assisted Urology Technologies

Continuous technological advancements are transforming the diagnosis and treatment of urological conditions by enhancing procedural precision, clinical outcomes, and patient safety. Manufacturers are developing advanced flexible and digital endoscopes, high-power laser lithotripsy systems, disposable ureteroscopes, AI-assisted imaging technologies, and robotic-assisted surgical platforms that enable minimally invasive procedures with smaller incisions, reduced blood loss, shorter hospital stays, and faster recovery. These innovations are increasing physician preference for minimally invasive approaches over conventional open surgery for treating kidney stones, prostate disorders, bladder conditions, and urological cancers.

In addition, the growing utilization of robotic-assisted surgery for procedures such as radical prostatectomy and partial nephrectomy is increasing demand for sophisticated urology devices across North America. Continued investments in research and development, regulatory clearances for next-generation technologies, and the integration of advanced visualization and digital navigation systems are further improving the accuracy and efficiency of urological procedures, positioning technological innovation as a key long-term growth driver for the North America urology devices market.

Restraints - High Cost of Advanced Urology Devices and Procedures

The high acquisition and operating costs associated with advanced urology devices remain a significant challenge to market expansion, particularly for healthcare facilities operating under constrained budgets. Robotic-assisted surgical platforms, laser lithotripsy equipment, digital endoscopy systems, urodynamic systems, and advanced imaging technologies require considerable capital expenditure, while maintenance, software upgrades, disposable accessories, and specialized staff training further increase the overall cost of ownership.

Hospitals and healthcare providers with limited financial resources continue using conventional equipment because of budgetary constraints, delaying the transition toward next-generation technologies.

In addition, variations in reimbursement coverage and patient out-of-pocket expenses for advanced minimally invasive procedures can restrict access to technologically sophisticated treatments. These financial barriers can limit the broader implementation of advanced urology devices and moderate market growth despite the clinical benefits associated with these technologies. The impact is particularly relevant for smaller healthcare facilities and providers seeking to upgrade their existing urological equipment and procedural infrastructure.

Shortage of Skilled Urologists and Technical Complexity of Advanced Procedures

The increasing adoption of sophisticated urology devices is challenged by the limited availability of experienced urologists and trained healthcare professionals capable of performing complex minimally invasive and robotic-assisted procedures. Advanced urology technologies require specialized clinical expertise, comprehensive training, and continuous skill development to ensure safe and effective utilization. Healthcare facilities in smaller communities and underserved areas face difficulties in accessing qualified specialists and establishing the infrastructure required for complex urological procedures.

The learning curve associated with robotic surgery, digital endoscopy, and advanced laser systems can initially affect procedural efficiency while increasing training and implementation costs for healthcare providers. Furthermore, the operation of sophisticated systems often requires coordinated teams of surgeons, nurses, and technical personnel with specialized knowledge. These workforce requirements, combined with differences in access to specialized healthcare services and advanced surgical infrastructure, continue to constrain the adoption of innovative urology technologies across certain areas of North America.

Opportunities - Growing Adoption of Robotic-Assisted Urological Surgery

The expanding adoption of robotic-assisted surgery presents a significant growth opportunity in the North America urology devices market, as healthcare providers increasingly invest in advanced surgical technologies that enhance procedural precision and patient outcomes.

Robotic surgical systems provide improved visualization, greater instrument precision, enhanced dexterity, and superior ergonomics, enabling surgeons to perform complex procedures such as radical prostatectomy, partial nephrectomy, bladder reconstruction, and pyeloplasty with greater control than conventional techniques. These systems can reduce surgical trauma, minimize blood loss, shorten hospital stays, and support faster patient recovery, increasing their utilization in minimally invasive urological procedures.

Rising investments in robotic surgical infrastructure, expanding surgeon training programs, increasing clinical evidence supporting robotic interventions, and growing patient preference for minimally invasive treatment are expected to strengthen demand for robotic-assisted urology devices throughout the forecast period. In addition, the expansion of robotic surgery programs across hospitals and specialty urology centers is expected to create opportunities for manufacturers of robotic platforms, instruments, visualization systems, and related accessories.

Increasing Demand for Advanced Kidney Stone Management Technologies

The increasing prevalence and recurrence of kidney stone disease across North America are creating substantial opportunities for manufacturers of laser lithotripsy systems, flexible ureteroscopes, stone retrieval devices, and related consumables. Healthcare providers are increasingly adopting advanced laser technologies and minimally invasive endoscopic procedures because these approaches offer high treatment effectiveness, improved procedural efficiency, reduced complications, and faster recovery compared with conventional surgical techniques.

At the same time, growing demand for disposable urology devices is supporting infection control, reducing sterilization requirements, and improving workflow efficiency across hospitals and ambulatory surgical centers. Continuous advancements in laser technology, flexible endoscopy, and stone visualization systems are further improving treatment capabilities. Increasing outpatient urology services, investments in advanced healthcare infrastructure, and rising demand for efficient kidney stone management are expected to generate significant long-term opportunities for manufacturers operating in the North America urology devices market.

Product Type Insights

Endoscopes are the leading product type segment, accounting for around 31.8% of the North America urology devices market share in 2026. Their leading position is supported by the extensive use of cystoscopes, ureteroscopes, nephroscopes, and resectoscopes for diagnosing and treating various urological conditions, including kidney stones, bladder cancer, benign prostatic hyperplasia (BPH), urethral strictures, and urinary tract abnormalities. Endoscopic procedures are increasingly preferred because they enable direct visualization of the urinary tract while minimizing surgical trauma, reducing hospital stays, and supporting faster patient recovery compared with conventional open procedures.

Technological advancements in high-definition digital imaging, flexible endoscopes, disposable ureteroscopes, and enhanced visualization systems have further improved procedural precision and physician confidence. In addition, the growing adoption of minimally invasive procedures, increasing urological procedure volumes, and ongoing product innovations by leading manufacturers are expected to sustain the strong position of endoscopes across hospitals, ambulatory surgical centers, and specialty urology clinics in North America.

Laser & lithotripsy devices are the fastest-growing product type segment in the North American urology devices market, driven by the rising prevalence of kidney stones, increasing adoption of minimally invasive stone-treatment procedures, and continued advances in laser technology. Growing preference for procedures that reduce recovery time, hospital stays, and surgical trauma is supporting greater adoption of laser-based lithotripsy across hospitals, ambulatory surgical centers, and urology clinics. The introduction of next-generation thulium fiber and advanced holmium laser systems is further improving stone fragmentation, procedural efficiency, and treatment precision.

Application Insights

Kidney Stone Disease (Urolithiasis) is the leading application segment, holding around 35.6% share of the North America urology devices market in 2026. The segment's leading position is primarily attributed to the high prevalence and recurrence of kidney stone disease, supported by factors such as changing dietary patterns, obesity, diabetes, inadequate hydration, and an aging population. Increasing patient awareness and broader access to minimally invasive treatment options, including ureteroscopy, laser lithotripsy, and percutaneous nephrolithotomy, are contributing to higher procedure volumes across hospitals, ambulatory surgical centers, and specialty urology clinics.

Continuous advancements in laser systems, flexible endoscopy, and stone retrieval technologies are improving treatment effectiveness while reducing complications and recovery periods. Furthermore, the recurrent nature of kidney stone disease and growing investments in advanced stone management technologies are expected to sustain demand for urology devices, supporting the segment's leading position throughout the forecast period.

End-User Analysis

Hospitals are projected to hold around 56.9% share of the North America urology devices market in 2026, making them the leading end-user segment. Their leading position is supported by access to advanced surgical infrastructure, comprehensive diagnostic facilities, specialized operating rooms, and multidisciplinary teams capable of managing both routine and complex urological conditions. A substantial proportion of procedures involving endoscopy, laser lithotripsy, robotic-assisted surgery, prostate treatment, and bladder cancer management are performed in hospitals because of their availability of advanced imaging systems, surgical facilities, intensive care units, and emergency services.

Hospitals also function as major referral centers for patients requiring complex urological interventions, postoperative monitoring, and specialized care. Moreover, investments in hospital modernization, increasing adoption of minimally invasive technologies, rising healthcare expenditure, and improved access to advanced urological services continue to support the dominant position of hospitals. At the same time, ambulatory surgical centers (ASCs) and specialty urology clinics are expanding their role in selected outpatient and minimally invasive procedures across North America.

U.S. Urology Devices Market Trends and Insights

The U.S. is expected to hold around 85.1% share of the North America urology devices market in 2026, supported by an extensive network of hospitals, ambulatory surgical centers, and specialty urology clinics, along with high procedural volumes, established reimbursement mechanisms, and strong adoption of advanced medical technologies. Increasing utilization of robotic-assisted surgery, laser lithotripsy, flexible ureteroscopy, and digital cystoscopy is contributing to the adoption of advanced urology devices. Strong research and development activities, regulatory support for innovative technologies, and the presence of major medical device manufacturers further strengthen the U.S. market.

The expanding elderly population and rising prevalence of chronic urological conditions are expected to sustain demand for diagnostic and therapeutic urology devices throughout the forecast period. Increasing investments in healthcare digitization and precision-based urological treatments are also creating opportunities for advanced imaging and monitoring technologies. Furthermore, the growing preference for minimally invasive and outpatient procedures is encouraging healthcare providers to upgrade their urology equipment and procedural capabilities.

Canada Urology Devices Market Trends and Insights

Canada is projected to hold around 14.9% share of the North America urology devices market in 2026, supported by increasing healthcare investments, an aging population, and the rising prevalence of kidney stones, urinary incontinence, prostate disorders, and other urological conditions. Hospitals and specialty healthcare facilities are increasing access to minimally invasive urological procedures through investments in advanced laser systems, digital endoscopy platforms, and robotic-assisted surgical technologies.

Government initiatives aimed at improving healthcare access and early diagnosis, together with collaborations between academic institutions, hospitals, and medical device manufacturers, are supporting the adoption of innovative urology technologies.

Furthermore, continued improvements in specialized urology services and healthcare infrastructure are expected to create additional opportunities for market participants in Canada. Growing demand for shorter hospital stays and efficient outpatient treatment is encouraging healthcare facilities to adopt minimally invasive technologies. Increasing physician training and the expansion of specialized urology services are also expected to improve access to advanced procedures across Canadian healthcare facilities.

The North America urology devices market is moderately consolidated, with Boston Scientific Corporation, Coloplast A/S, Becton, Dickinson and Company, Teleflex Incorporated, and Olympus Corporation leading the competitive landscape through broad product portfolios, strong global distribution networks, and continuous product innovation. These companies focus on expanding their presence through advanced endoscopy systems, urinary catheters, laser lithotripsy devices, and minimally invasive surgical technologies.

Meanwhile, B. Braun Melsungen AG, Intuitive Surgical, Inc., Medtronic plc, KARL STORZ SE & Co. KG, Cook Medical LLC, and other regional players continue to strengthen market competition through product launches, strategic collaborations, and geographic expansion.

Key Industry Developments

• In March 2026, Cook Medical commercially launched the Syfonix Suction Ureteral Access Sheath and the 7.5 Fr Ascend Single-Use Flexible Ureteroscope in the U.S. and Canada, expanding its portfolio of minimally invasive urology devices for stone management procedures.
• In December 2025, Medtronic received U.S. FDA clearance for its Hugo robotic-assisted surgery (RAS) system for urologic surgical procedures, expanding access to minimally invasive robotic surgery for hospitals and surgeons across the United States.